Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iain Stephenson

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Heart Valve Disease|November 5, 2008
Identification of Streptococcus gallolyticus subsp. macedonicus as the etiological agent in a case of culture-negative multivalve infective endocarditis by 16S rDNA PCR analysis of resected valvular tissueJoanne Malkin, Patrick T Kimmitt, Hong-Yu Ou, et al.
Emerging Infectious Diseases|September 16, 2009
Reproducibility of serologic assays for influenza virus A (H5N1)Iain Stephenson, Alan Heath, Diane Major, et al.
Lancet (London, England)|December 20, 2003
Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trialIain Stephenson, Karl G Nicholson, Reinhardt Glück, et al.
Lancet (London, England)|February 14, 2006
Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in miceMary A Hoelscher, Sanjay Garg, Dinesh S Bangari, et al.
The Lancet. Infectious Diseases|August 6, 2022
Is the UK prepared for seasonal influenza in 2022-23 and beyond?Joshua Nazareth, Daniel Pan, Christopher A Martin, et al.
Plos One|February 2, 2013
Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccineRichard Puleston, George Bugg, Katja Hoschler, et al.
Vaccine|October 13, 2006
Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) virusesXiuhua Lu, Lindsay E Edwards, Julia A Desheva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 19, 2005
Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care centerAnucha Apisarnthanarak, Steven Erb, Iain Stephenson, et al.
Journal of Virology|April 28, 2006
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteersIain Stephenson, Maria C Zambon, Anna Rudin, et al.
HIV Medicine|September 24, 2024
Cardiovascular medication adherence testing in patients living with HIV: A single-centre observational studyJoshua Nazareth, Ayobami Adebayo, Muhammad Fahad, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Heart Valve Disease|November 5, 2008
Identification of Streptococcus gallolyticus subsp. macedonicus as the etiological agent in a case of culture-negative multivalve infective endocarditis by 16S rDNA PCR analysis of resected valvular tissueJoanne Malkin, Patrick T Kimmitt, Hong-Yu Ou, et al.
Emerging Infectious Diseases|September 16, 2009
Reproducibility of serologic assays for influenza virus A (H5N1)Iain Stephenson, Alan Heath, Diane Major, et al.
Lancet (London, England)|December 20, 2003
Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trialIain Stephenson, Karl G Nicholson, Reinhardt Glück, et al.
Lancet (London, England)|February 14, 2006
Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in miceMary A Hoelscher, Sanjay Garg, Dinesh S Bangari, et al.
The Lancet. Infectious Diseases|August 6, 2022
Is the UK prepared for seasonal influenza in 2022-23 and beyond?Joshua Nazareth, Daniel Pan, Christopher A Martin, et al.
Plos One|February 2, 2013
Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccineRichard Puleston, George Bugg, Katja Hoschler, et al.
Vaccine|October 13, 2006
Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) virusesXiuhua Lu, Lindsay E Edwards, Julia A Desheva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 19, 2005
Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care centerAnucha Apisarnthanarak, Steven Erb, Iain Stephenson, et al.
Journal of Virology|April 28, 2006
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteersIain Stephenson, Maria C Zambon, Anna Rudin, et al.
HIV Medicine|September 24, 2024
Cardiovascular medication adherence testing in patients living with HIV: A single-centre observational studyJoshua Nazareth, Ayobami Adebayo, Muhammad Fahad, et al.
Pageof 6